The global coronary stents market was valued at USD 6.68 billion in 2024 and is expected to grow to USD 10.66 billion by 2032, reflecting a compound annual growth rate (CAGR) of 6.2% during the forecast period. In 2024, North America held the leading position in the market, accounting for a 33.08% share.
The coronary stents market plays a vital role in the treatment of coronary artery disease, offering minimally invasive solutions to restore blood flow in blocked or narrowed arteries. These small, expandable devices are widely used in angioplasty procedures to support arterial walls and reduce the risk of future blockages. With the increasing prevalence of cardiovascular diseases, changing lifestyles, and advancements in interventional cardiology, demand for coronary stents continues to grow. Innovations such as drug-eluting stents, bioresorbable stents, and improved stent delivery systems are enhancing clinical outcomes and patient recovery. As healthcare systems prioritize faster, safer, and more effective treatment options, the coronary stents market is poised for continued evolution and global expansion.
Continue reading for more details:
https://www.fortunebusinessinsights.com/industry-reports/coronary-stents-market-100065
Coronary Stents Market Overview & Key Metrics
Market Size & Forecast:
2024 Market Size: USD 6.68 billion
2025 Market Size: USD 7.02 billion
2032 Forecast Market Size: USD 10.66 billion
CAGR: 6.2% from 2025–2032
Market Share:
North America dominated the coronary stents market with a 33.08% share in 2024, driven by a robust healthcare infrastructure, high CAD prevalence, and frequent product launches backed by regulatory approvals in the U.S.
By stent type, drug-eluting stents (DES) are projected to maintain the largest market share in 2025, due to growing clinical demand, increasing launches, and regulatory approvals. Their ability to reduce restenosis rates contributes to widespread clinical preference.
Key Country Highlights:
Japan: Growth is supported by an aging population susceptible to CAD, growing hospital infrastructure, and regulatory support for advanced coronary devices. The presence of local players like Terumo fosters product accessibility.
United States: High disease burden, advanced cardiac care centers, and product innovations by key players (e.g., Abbott, Medtronic) contribute to increased adoption. Regulatory approvals, like the FDA clearance of new DES systems, also accelerate market growth.
China: Rising CAD prevalence, increasing awareness, and the expansion of specialty hospitals and catheterization labs are key growth drivers. Domestic manufacturers like MicroPort are expanding rapidly with government approvals, including NMPA authorization for bioresorbable stents.
Europe: Market growth is supported by CE-mark approvals and increasing preference for PCI procedures. Countries like Germany and the U.K. are expanding their interventional cardiology services, and major players are launching advanced DES platforms in the region.
Market Segmentation
By Product Type
Bare-metal stents (BMS)
Drug-eluting stents (DES)
Bioresorbable vascular scaffolds (BVS)
By Material
Metallic stents
Polymer-based stents
Hybrid stents
By End User
Hospitals
Ambulatory surgical centers
Cardiac centers
Specialty clinics
By Mode of Delivery
Balloon-expandable stents
Self-expanding stents
List Of Key Coronary Stents Market Companies Profiled:
Medtronic (Ireland)
Boston Scientific Corporation (U.S.)
BIOTRONIK SE & Co. KG (Germany)
Terumo Corporation (Japan)
Abbott (U.S.)
Relisys Medical Devices Limited. (India)
Braun SE (Germany)
MicroPort Scientific Corporation (China)
Stentys S.A. (France)
Meril Life Sciences Pvt. Ltd. (India)
Market Growth
The coronary stents market is experiencing steady growth due to the increasing prevalence of coronary artery disease and rising demand for minimally invasive procedures.
Advancements in stent technology, including drug-eluting stents and bioresorbable stents, are significantly boosting the coronary stents market.
Growing geriatric population and a sedentary lifestyle are contributing to the rising incidence of heart-related disorders, fueling the coronary stents market.
Increasing healthcare expenditure and the expansion of interventional cardiology procedures are supporting the growth of the coronary stents market.
Favorable reimbursement policies and the availability of technologically advanced products are further enhancing the outlook for the coronary stents market.
Restraining Factors
High cost of advanced stent systems may limit access in price-sensitive markets, affecting the coronary stents market.
Risk of post-surgical complications such as restenosis and thrombosis continues to be a concern in the coronary stents market.
Stringent regulatory approval processes can delay product launches in the coronary stents market.
Limited healthcare infrastructure in rural and underserved regions can restrict the expansion of the coronary stents market.
Availability of alternative treatments like coronary artery bypass grafting (CABG) may also pose a challenge for the coronary stents market.
Regional Analysis
North America
Leads the coronary stents market due to high incidence of cardiovascular diseases, advanced healthcare systems, and early adoption of new technologies.
Europe
The coronary stents market in Europe is growing steadily, supported by increasing awareness, healthcare funding, and the presence of key market players.
Asia Pacific
Shows the fastest growth in the coronary stents market, driven by a large patient pool, improving medical infrastructure, and rising healthcare investment.
Latin America
Demonstrates moderate growth in the coronary stents market due to expanding access to healthcare and the adoption of minimally invasive cardiac procedures.
Middle East & Africa
The coronary stents market is gradually developing in this region, with growth supported by rising healthcare modernization and increasing prevalence of heart disease.